Publications by authors named "Thomas J Prior"

Claim this Profile
T
Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study.
Ajai Chari, Niels W C J van de Donk, Bhagirathbhai Dholaria, Katja Weisel, María-Victoria Mateos, Thomas J Prior

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual disease (MRD) as a surrogate end point for clinical drug approval in acute myeloid leukemia (AML): Perspectives from the MRD Partnership and Alliance in AML Clinical Treatment Consortium.
Michael Boyiadzis, Andrew H Wei, Bruno Paiva, Sylvie D Freeman, Gertjan Kaspers, Thomas J Prior

Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling MRD Changes in Myeloma to Understand Treatment Effects, Predict Outcomes, and Investigate Curative Potential.
Walter M Gregory, Thomas J Prior, J Blake Bartlett, Pieter Sonneveld, Meletios A Dimopoulos

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal Residual Disease-Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials.
Qian Shi, Bruno Paiva, Levi D Pederson, Natalie Dimier, Ela Talpes, Thomas J Prior

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma.
Ola Landgren, Thomas J Prior, Tara Masterson, Christoph Heuck, Orlando F Bueno

Blood· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Group sequential monitoring based on the maximum of weighted log-rank statistics with the Fleming-Harrington class of weights in oncology clinical trials.
Thomas J Prior

Stat Methods Med Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of two experimental design approaches in applying conjoint analysis in patient-centered outcomes research: a randomized trial.
Elizabeth T Kinter, Thomas J Prior, Christopher I Carswell, John F P Bridges

Patient· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis